Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026)
Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 22.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 48.73% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -20.41% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -4.01% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 3.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -72.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -0.07% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | -3.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -0.37% |
| 10 | Myriad Genetics | 297.97 Mn | 173.57 Mn | 137.60 Mn | 102.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.87% |
| Dec 31, 2025 | 202.78% |
| Sep 30, 2025 | 206.41% |
| Jun 30, 2025 | 53.09% |
| Mar 31, 2025 | 53.23% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 1.04% |
| Jun 30, 2021 | -8.48% |
| Mar 31, 2021 | -32.54% |
| Dec 31, 2020 | -1.62% |
| Sep 30, 2020 | -0.18% |
| Jun 30, 2020 | -3.97% |
| Mar 31, 2020 | -14.53% |
| Dec 31, 2019 | -17.98% |
| Sep 30, 2019 | -13.29% |
| Jun 30, 2019 | 1,522.60% |
| Mar 31, 2019 | 248.24% |
| Dec 31, 2018 | 146.11% |
| Sep 30, 2018 | 105.38% |